Literature DB >> 6330175

Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.

W B Davis, G A Fells, X H Sun, J E Gadek, A Venet, R G Crystal.   

Abstract

Eosinophils are a common component of the inflammation of the lower respiratory tract that characterizes the interstitial lung disorders. Bronchoalveolar lavage analyses (n = 680) of 251 patients with interstitial lung disease demonstrated that eosinophils represented greater than 5% of the effector cells comprising the alveolitis in 20% of all lavages. In contrast, lavage of normal individuals (n = 117) showed that eosinophils were never greater than 5% of the total effector cells recovered. To evaluate a possible role for eosinophils in mediating some of the cellular and connective tissue matrix derangements of the lung parenchyma found in interstitial disease, eosinophils were evaluated for the presence of proteases capable of cleaving connective tissue proteins found in the lung and for the ability to mediate cytotoxicity to lung parenchymal cells. Evaluation of guinea pig and human eosinophils demonstrated that eosinophil granules contained a collagenase that specifically cleaved human collagen types I and III, the two major connective tissue components of the human lung parenchyma. In contrast, the eosinophil did not contain an elastase or a nonspecific neutral protease. The eosinophil collagenase appeared to be a metalloprotease, as it was inhibited by ethylenediaminetetraacetate but not by phenylmethanesulfonyl-fluoride or alpha 1-antitrypsin. The eosinophil also has the capacity to injure lung parenchymal cells. Without further stimulation, eosinophils purified from peritoneal exudates of guinea pigs demonstrated spontaneous cytotoxicity for human lung fibroblasts (HFL-1), cat lung epithelial cells (AK-D) and rat lung mesothelial cells (I6B). Under identical conditions, the epithelial cells were more sensitive to eosinophil-mediated cytotoxicity than the fibroblasts or mesothelial cells (P less than 0.01), consistent with the clinical observation that in the interstitial disorders, the alveolar epithelial cells are damaged more commonly than fibroblasts or pleural cells. The eosinophil-mediated cytotoxicity could be partially inhibited by the antioxidants catalase and dimethylsulfoxide suggesting that toxic oxygen radicals play a role in mediating the cellular damage. Importantly, eosinophils purified from bronchoalveolar lavage of human interstitial lung disease also demonstrated spontaneous cytotoxicity for lung epithelial cells. These observations demonstrate that eosinophils are frequent participants of the alveolitis of the interstitial lung disorders and suggest that these cells have the potential to damage the parenchymal cells and collagen matrix of the lower respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330175      PMCID: PMC425209          DOI: 10.1172/JCI111411

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a).

Authors:  A B Kay; H S Shin; K F Austen
Journal:  Immunology       Date:  1973-06       Impact factor: 7.397

2.  The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.

Authors:  A B Kay; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

3.  Specific degradation of the collagen molecule by tadpole collagenolytic enzyme.

Authors:  J Gross; Y Nagai
Journal:  Proc Natl Acad Sci U S A       Date:  1965-10       Impact factor: 11.205

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids.

Authors:  G J Gleich; D Loegering
Journal:  J Lab Clin Med       Date:  1973-09

Review 6.  The eosinophilic pneumonias.

Authors:  A A Liebow; C B Carrington
Journal:  Medicine (Baltimore)       Date:  1969-07       Impact factor: 1.889

7.  Chronic eosinophilic pneumonia.

Authors:  C B Carrington; W W Addington; A M Goff; I M Madoff; A Marks; J R Schwaber; E A Gaensler
Journal:  N Engl J Med       Date:  1969-04-10       Impact factor: 91.245

8.  Identification of a major basic protein in guinea pig eosinophil granules.

Authors:  G J Gleich; D A Loegering; J E Maldonado
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

9.  Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules.

Authors:  G J Gleich; D A Loegering; F Kueppers; S P Bajaj; K G Mann
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

10.  An eosinophil leukocyte chemotactic factor of anaphylaxis.

Authors:  A B Kay; D J Stechschulte; K F Austen
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

View more
  35 in total

Review 1.  Update on reslizumab for eosinophilic asthma.

Authors:  Juan Carlos Cardet; Elliot Israel
Journal:  Expert Opin Biol Ther       Date:  2015       Impact factor: 4.388

2.  Role of airway eosinophilia and eosinophil activation in Sephadex-induced inflammation.

Authors:  Karim Maghni; François Nantel; Chantal Lanoue; Solange Cloutier; Jean-Paul Cristol; Alain Cadieux; Pierre Sirois
Journal:  Inflammation       Date:  2004-08       Impact factor: 4.092

3.  In vitro modulation of the eosinophil-dependent enhancement of the permeability of the bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

4.  Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract.

Authors:  A M Cantin; G A Fells; R C Hubbard; R G Crystal
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 5.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

Review 6.  The IgE receptor of eosinophils.

Authors:  M Capron; L Prin
Journal:  Springer Semin Immunopathol       Date:  1990

7.  Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury.

Authors:  J Xu; G M Kim; S H Ahmed; J Xu; P Yan; X M Xu; C Y Hsu
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

8.  Eosinophils are an insignificant cellular component of rheumatoid synovium in patients with late stage disease: comparative distributions with mast cells and macrophages.

Authors:  L C Tetlow; D E Woolley
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

9.  Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.

Authors:  M Miyasato; S Tsuda; M Kasada; K Iryo; Y Sasai
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

10.  Local lung responses following endobronchial elastase and lipopolysaccharide instillation in sheep.

Authors:  D David S Collie; Nicola McLean; Jean-Michel Sallenave; Alison Baker; Richard Blundell; Elspeth Milne; Susan Rhind; Chris Woodall
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.